FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines.
Chen
S
S
Department of Immunology, The Scripps Research Institute, La Jolla, California, USA.
Bacon
K B
KB
Garcia
G
G
Liao
R
R
Pan
Z K
ZK
Sullivan
S K
SK
Nakano
H
H
Matsuzawa
A
A
Brinkmann
V
V
Feng
L
L
D000818:Animals; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology; D018925:Chemokines / Q000276:immunology*; D000068876:Fingolimod Hydrochloride; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007970:Leukopenia / Q000139:chemically induced; D008214:Lymphocytes / Q000187:drug effects / Q000502:physiology*; D008231:Lymphopenia / Q000139:chemically induced; D051379:Mice; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D011409:Propylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives; D014181:Transplantation Immunology
D018925:Chemokines; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D019869:Phosphatidylinositol 3-Kinases; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine